Tag: Tucatinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Tucatinib

MacroGenics' HER2 breast cancer drug Margenza approved in US

Added to Collection on: 2020-12-18 11:03:45

Tags for this article:

Clinical medicine
Drugs
Medicine
Antineoplastic drugs
Cancer treatments
Breakthrough therapy
Orphan drugs
Immunology
Trastuzumab
HER2/neu
Trastuzumab emtansine
Tucatinib
Roche
MacroGenics

Click the tags to see associated articles and topics

View Article Details
Here's Why Seagen Jumped Higher Today

Added to Collection on: 2021-02-05 22:41:15

Tags for this article:

Finance
Money
Financial markets
Seagen
Institutional investors
Exchange-traded fund
Mutual fund
Tucatinib
Traders
Stock
Short
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Insider Selling: Seagen Inc. (NASDAQ:SGEN) CEO Sells 12602 Shares of Stock

Added to Collection on: 2021-04-11 00:00:00

Tags for this article:

Financial markets
Finance
Stock market
Equity securities
Financial economics
Corporate finance
Seagen
Stock
Share
Tucatinib
Amundi
NASDAQ
Seagen Inc.

Click the tags to see associated articles and topics

View Article Details
Ambrx tries another IPO as it chases down HER2 rivals

Added to Collection on: 2021-06-16 09:00:00

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Breakthrough therapy
Trastuzumab emtansine
HER2/neu
Trastuzumab
Pertuzumab
Tucatinib

Click the tags to see associated articles and topics

View Article Details
Mayo Clinic Comprehensive Cancer Center to highlight key studies at ASCO 2024

Added to Collection on: 2024-05-30 22:18:46

Tags for this article:

Cancer treatments
Oncology
PROTON
Proton therapy
Head and neck cancer
Adjuvant therapy
Radiation oncologist
Tucatinib
Cancer
Mayo Clinic Communications

Click the tags to see associated articles and topics

View Article Details
Tucatinib Plus Trastuzumab Shows "Clinically Meaningful" Activity in HER2+ Metastatic CRC

Added to Collection on: 2024-06-18 16:05:03

Tags for this article:

Cancer treatments
Antineoplastic drugs
Orphan drugs
Quinazolines
Immunology
Tucatinib
Trastuzumab
HER2
Seagen
Trastuzumab emtansine
John H. Strickler

Click the tags to see associated articles and topics

View Article Details
Evolving Treatment Strategies in Early HER2+ Breast Cancer

Added to Collection on: 2025-03-20 17:29:53

Tags for this article:

Breast cancer
Cancer treatments
Antineoplastic drugs
HER2
Oncogenes
Tucatinib
Brain metastasis
Metastatic breast cancer
Trastuzumab emtansine
Circulating tumor cell

Click the tags to see associated articles and topics

View Article Details
Expert Insights: Later-Line Treatment Strategies for HER2+ Metastatic Breast Cancer

Added to Collection on: 2025-07-08 13:19:16

Tags for this article:

Antineoplastic drugs
Orphan drugs
Breast cancer
Cancer treatments
Immunology
HER2
Trastuzumab emtansine
Margetuximab
Trastuzumab
Antibody-drug conjugate
Pertuzumab
Tucatinib

Click the tags to see associated articles and topics

View Article Details
Pfizer's Latest Study on HER2-positive Breast Cancer Treatment: What Investors Need to Know

Added to Collection on: 2025-07-09 16:12:03

Tags for this article:

Orphan drugs
Cancer treatments
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Tucatinib
HER2
Trastuzumab
Breast cancer
Pfizer
Trastuzumab emtansine
Xavier Pivot
Intel
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
Pfizer's Latest Study on HER2-positive Breast Cancer: Key Insights for Investors

Added to Collection on: 2025-08-14 16:33:25

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugates
Cancer treatments
Quinazolines
Tucatinib
Trastuzumab deruxtecan
HER2
Trastuzumab
Breast cancer
Deruxtecan
Trastuzumab emtansine
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo